SE7409891L - - Google Patents

Info

Publication number
SE7409891L
SE7409891L SE7409891A SE7409891A SE7409891L SE 7409891 L SE7409891 L SE 7409891L SE 7409891 A SE7409891 A SE 7409891A SE 7409891 A SE7409891 A SE 7409891A SE 7409891 L SE7409891 L SE 7409891L
Authority
SE
Sweden
Application number
SE7409891A
Inventor
J W Mcginity
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of SE7409891L publication Critical patent/SE7409891L/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE7409891A 1973-08-01 1974-07-31 SE7409891L (2)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US384551A US3898330A (en) 1973-08-01 1973-08-01 Corticosteroid phosphate salts/neomycin sulfate ophthalmic

Publications (1)

Publication Number Publication Date
SE7409891L true SE7409891L (2) 1975-02-03

Family

ID=23517768

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7409891A SE7409891L (2) 1973-08-01 1974-07-31

Country Status (12)

Country Link
US (1) US3898330A (2)
JP (1) JPS5042026A (2)
BE (1) BE818410A (2)
CA (1) CA1031262A (2)
DE (1) DE2437145A1 (2)
DK (1) DK134924B (2)
FR (1) FR2240013B1 (2)
GB (1) GB1471326A (2)
NL (1) NL7410297A (2)
NO (1) NO141394C (2)
SE (1) SE7409891L (2)
ZA (1) ZA744703B (2)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223022A (en) * 1978-01-16 1980-09-16 Schering Corporation Stabilized aminoglycoside antibiotic formulations
IT8148073A0 (it) * 1980-03-21 1981-03-20 Wellcome Found Formulazione oftalmica a base di trimethoprim e di polymyxin contenente un agente stabilizzante a base di mercurio
US5883074A (en) * 1995-02-08 1999-03-16 Microcide Pharmaceuticals, Inc. Potentiators of antibacterial agents
US6843983B2 (en) * 2001-06-07 2005-01-18 Virgie Bright-Ellington Shaving preparations and methods for the prevention and treatment of pseudofolliculitis barbae
ES2384641T3 (es) 2005-07-14 2012-07-10 Lithera, Inc. Formulación lipolítica que potencia la liberación mantenida para el tratamiento localizado del tejido adiposo
AU2007313077B2 (en) * 2006-10-17 2011-06-02 Neothetics, Inc. Methods, compositions, and formulations for the treatment of thyroid eye disease
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
EP2646012A4 (en) 2010-11-24 2014-12-10 Neothetics Inc MONOTHERAPEUTIC FORMULATIONS OF SELECTIVE, LIPOPHILIC AND PROLONGED BETA AGONISTS AND METHODS OF COSMETIC TREATMENT OF SILHOUETTE ADPOSITY AND REINFORCEMENT
BR102012030828A2 (pt) 2012-12-03 2014-09-16 Ems Sa Composição farmacêutica compreendendo desloratadina e prednisolona e seu uso

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3105795A (en) * 1957-02-12 1963-10-01 Schering Corp 9alpha-fluoro-15beta-hydroxy-1, 4-pregnadienes and pharmaceutical preparations containing same
US3146164A (en) * 1960-08-09 1964-08-25 Merck & Co Inc Solutions of steroid phosphate and basic antibiotics stabilized with creatinine
US3138528A (en) * 1962-05-01 1964-06-23 Olin Mathieson Stable, aqueous solutions of 21-phosphate esters of 21-hydroxy steroids
US3317384A (en) * 1964-06-08 1967-05-02 Upjohn Co Treatment of topical viral infections with glucocorticoids and nucleosides

Also Published As

Publication number Publication date
FR2240013A1 (2) 1975-03-07
FR2240013B1 (2) 1977-11-04
US3898330A (en) 1975-08-05
NL7410297A (nl) 1975-02-04
DK134924C (2) 1977-08-01
NO742767L (2) 1975-03-03
DK409774A (2) 1975-04-01
CA1031262A (en) 1978-05-16
ZA744703B (en) 1975-07-30
JPS5042026A (2) 1975-04-16
NO141394B (no) 1979-11-26
GB1471326A (en) 1977-04-21
BE818410A (fr) 1975-02-03
NO141394C (no) 1980-03-05
DE2437145A1 (de) 1975-02-13
DK134924B (da) 1977-02-14
AU7159874A (en) 1976-01-29

Similar Documents

Publication Publication Date Title
AR201758A1 (2)
AU476761B2 (2)
AU465372B2 (2)
AR201235Q (2)
AR201231Q (2)
AU474593B2 (2)
AU474511B2 (2)
AU474838B2 (2)
AU465453B2 (2)
AU465434B2 (2)
AU476714B2 (2)
DK134924C (2)
AR201229Q (2)
AU472848B2 (2)
AU466283B2 (2)
AR199451A1 (2)
AU477823B2 (2)
AR200256A1 (2)
AR195948A1 (2)
AU476873B1 (2)
AR201432A1 (2)
AR200885A1 (2)
AU477824B2 (2)
AU447540B2 (2)
AR210729A1 (2)